Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Change in Account Payables (2022 - 2025)

Core Laboratories (CLB) has 4 years of Change in Account Payables data on record, last reported at -$5.4 million in Q3 2025.

  • For Q3 2025, Change in Account Payables fell 53.71% year-over-year to -$5.4 million; the TTM value through Sep 2025 reached $2.2 million, up 1550.67%, while the annual FY2024 figure was $519000.0, 104.03% up from the prior year.
  • Change in Account Payables reached -$5.4 million in Q3 2025 per CLB's latest filing, down from $3.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $11.1 million in Q4 2022 and bottomed at -$7.1 million in Q1 2023.
  • Average Change in Account Payables over 4 years is -$58692.3, with a median of -$551000.0 recorded in 2024.
  • Peak YoY movement for Change in Account Payables: plummeted 470.54% in 2023, then soared 639.2% in 2025.
  • A 4-year view of Change in Account Payables shows it stood at $11.1 million in 2022, then plummeted by 97.99% to $223000.0 in 2023, then surged by 300.0% to $892000.0 in 2024, then crashed by 701.23% to -$5.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$5.4 million in Q3 2025, $3.7 million in Q2 2025, and $3.0 million in Q1 2025.